NO953892D0 - Imidazoloquinoxalinone derivatives as EAA antagonists - Google Patents
Imidazoloquinoxalinone derivatives as EAA antagonistsInfo
- Publication number
- NO953892D0 NO953892D0 NO953892A NO953892A NO953892D0 NO 953892 D0 NO953892 D0 NO 953892D0 NO 953892 A NO953892 A NO 953892A NO 953892 A NO953892 A NO 953892A NO 953892 D0 NO953892 D0 NO 953892D0
- Authority
- NO
- Norway
- Prior art keywords
- imidazoloquinoxalinone
- derivatives
- preparation
- eaa antagonists
- eaa
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Described are imidazoloquinoxalinones of the formula (I) in which A and R1 to R6 are as defined in the description, plus their preparation. The compounds described can be used in the preparation of drugs for use in the treatment of neurodegenerative ailments and neurotoxic disorders of the central nervous system as well as in the preparation of spasmolytics, anti-epileptics, anxiolytics and anti-depressants.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4310521 | 1993-03-31 | ||
DE4329970A DE4329970A1 (en) | 1993-03-31 | 1993-09-04 | New imidazolo-quinoxalinones, their manufacture and use |
PCT/EP1994/000871 WO1994022865A1 (en) | 1993-03-31 | 1994-03-19 | Imidazoloquinoxalinone derivatives as eaa antagonists |
Publications (2)
Publication Number | Publication Date |
---|---|
NO953892L NO953892L (en) | 1995-09-29 |
NO953892D0 true NO953892D0 (en) | 1995-09-29 |
Family
ID=25924528
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO953892A NO953892D0 (en) | 1993-03-31 | 1995-09-29 | Imidazoloquinoxalinone derivatives as EAA antagonists |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0691970B1 (en) |
JP (1) | JPH08508271A (en) |
CN (1) | CN1041928C (en) |
AT (1) | ATE173263T1 (en) |
AU (1) | AU6428294A (en) |
BR (1) | BR9406034A (en) |
CA (1) | CA2158167A1 (en) |
CZ (1) | CZ246495A3 (en) |
FI (1) | FI954614A0 (en) |
HR (1) | HRP940210A2 (en) |
HU (1) | HUT73970A (en) |
IL (1) | IL109076A (en) |
NO (1) | NO953892D0 (en) |
NZ (1) | NZ263552A (en) |
PL (1) | PL310950A1 (en) |
SI (1) | SI9420023A (en) |
WO (1) | WO1994022865A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUT76323A (en) * | 1994-02-11 | 1997-08-28 | Novo Nordisk As | Imidazo[1,2-a]quinoxalinone derivatives, process for their preparation and pharmaceutical compositions containing them |
FR2722789B1 (en) * | 1994-07-20 | 1996-08-23 | Rhone Poulenc Rorer Sa | IMIDAZO (1,2-A) INDENO (1,2-E) PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES, THEIR PREPARATION AND THE MEDICINAL PRODUCTS CONTAINING THEM |
IT1276167B1 (en) * | 1995-11-24 | 1997-10-27 | Foscama Biomed Chim Farma | IMIDAZO (1,2-ALPHA) QUINOSSALIN-4-AMINE ACTIVE AS ADENOSINE ANTAGONISTS, PROCEDURE FOR THEIR PREPARATION AND COMPOSITIONS |
FR2743363A1 (en) * | 1996-01-10 | 1997-07-11 | Rhone Poulenc Rorer Sa | 5H, 10H-IMIDAZO (1,2-A) INDENO (1,2-E) PYRAZINE-A-ONES SUBSTITUTED IN POSITION 2, THEIR PREPARATION AND THE MEDICINAL PRODUCTS CONTAINING THEM |
US6271418B1 (en) * | 2000-02-22 | 2001-08-07 | Nippon Kayaku Co., Ltd. | Process for preparing (hetero) aromatic substituted benzene derivatives |
GB0017518D0 (en) | 2000-07-17 | 2000-08-30 | Merck Sharp & Dohme | Therapeutic agents |
GB0018473D0 (en) | 2000-07-27 | 2000-09-13 | Merck Sharp & Dohme | Therapeutic agents |
CN100386326C (en) * | 2003-10-22 | 2008-05-07 | 中国人民解放军军事医学科学院毒物药物研究所 | 1-methylolimidazole [1,2-alpha] quinoxaline compound and its application |
EP2489667B1 (en) * | 2006-12-13 | 2015-04-15 | ASKA Pharmaceutical Co., Ltd. | Quinoxaline derivative |
FR2921927B1 (en) * | 2007-10-03 | 2012-10-12 | Univ De Montpellier 1 | IMIDAZO® 1,2-A! QUINOXALINS AND DERIVATIVES FOR THE TREATMENT OF CANCER |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2043064B (en) * | 1979-02-09 | 1983-04-13 | Roussel Lab Ltd | Oximidazoquinoxaline derivatives |
US5153196A (en) * | 1991-06-05 | 1992-10-06 | Eli Lilly And Company | Excitatory amino acid receptor antagonists and methods for the use thereof |
US5182386A (en) * | 1991-08-27 | 1993-01-26 | Neurogen Corporation | Certain imidazoquinoxalinones; a new class of gaba brain receptor ligands |
-
1994
- 1994-03-19 CA CA002158167A patent/CA2158167A1/en not_active Abandoned
- 1994-03-19 AT AT94911932T patent/ATE173263T1/en not_active IP Right Cessation
- 1994-03-19 CN CN94191613A patent/CN1041928C/en not_active Expired - Fee Related
- 1994-03-19 JP JP6521617A patent/JPH08508271A/en active Pending
- 1994-03-19 HU HU9502848A patent/HUT73970A/en unknown
- 1994-03-19 PL PL94310950A patent/PL310950A1/en unknown
- 1994-03-19 AU AU64282/94A patent/AU6428294A/en not_active Abandoned
- 1994-03-19 NZ NZ263552A patent/NZ263552A/en unknown
- 1994-03-19 EP EP94911932A patent/EP0691970B1/en not_active Expired - Lifetime
- 1994-03-19 SI SI9420023A patent/SI9420023A/en unknown
- 1994-03-19 CZ CZ952464A patent/CZ246495A3/en unknown
- 1994-03-19 BR BR9406034A patent/BR9406034A/en not_active Application Discontinuation
- 1994-03-19 WO PCT/EP1994/000871 patent/WO1994022865A1/en active IP Right Grant
- 1994-03-22 IL IL109076A patent/IL109076A/en not_active IP Right Cessation
- 1994-03-30 HR HRP4329970.9A patent/HRP940210A2/en not_active Application Discontinuation
-
1995
- 1995-09-28 FI FI954614A patent/FI954614A0/en not_active Application Discontinuation
- 1995-09-29 NO NO953892A patent/NO953892D0/en unknown
Also Published As
Publication number | Publication date |
---|---|
NO953892L (en) | 1995-09-29 |
EP0691970B1 (en) | 1998-11-11 |
ATE173263T1 (en) | 1998-11-15 |
CZ246495A3 (en) | 1996-03-13 |
FI954614A (en) | 1995-09-28 |
FI954614A0 (en) | 1995-09-28 |
CN1041928C (en) | 1999-02-03 |
CN1120336A (en) | 1996-04-10 |
NZ263552A (en) | 1997-06-24 |
BR9406034A (en) | 1996-01-02 |
AU6428294A (en) | 1994-10-24 |
JPH08508271A (en) | 1996-09-03 |
HRP940210A2 (en) | 1996-12-31 |
EP0691970A1 (en) | 1996-01-17 |
IL109076A0 (en) | 1994-06-24 |
HU9502848D0 (en) | 1995-11-28 |
CA2158167A1 (en) | 1994-10-13 |
WO1994022865A1 (en) | 1994-10-13 |
IL109076A (en) | 1997-06-10 |
PL310950A1 (en) | 1996-01-08 |
SI9420023A (en) | 1996-04-30 |
HUT73970A (en) | 1996-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO923975L (en) | 2-aminomethyl-chromans | |
NO20050807L (en) | Pharmaceutical compositions including dextromethorphan and quinidine for the treatment of neurological disorders | |
DK0668863T3 (en) | Quinuclidine derivative as substance P antagonist | |
GR3019450T3 (en) | Azaheterocyclylmethyl-chromans as agents for the treatment of diseases of the central nervous system | |
MY110110A (en) | Pharmaceuticals in the treatment of gastrointestinal disorders, cardiovascular disorders and cns disorders | |
DK0751939T5 (en) | Naphthylamides as central nervous system agents | |
IS1904B (en) | Analogous Methods for Preparation of New (R) -5-Carbamoyl-8-Fluoro-3-N, N-Divided-Amino-3,4-Dihydro-2H-1-Benzopyranes | |
DK0713701T3 (en) | 2-Bromelatonin for the treatment of sleep disorders | |
ATE77747T1 (en) | 3-(AMINOPROPYL)METHYLPHOSPHIC ACID AS A THERAPEUTIC AGENT. | |
DK0687176T3 (en) | Use of riluzole for the treatment of AIDS-related nervous disorders | |
SE9702564D0 (en) | New compounds | |
DK0520200T3 (en) | Imadazole compounds, their preparation and use | |
NO953892D0 (en) | Imidazoloquinoxalinone derivatives as EAA antagonists | |
ATE381533T1 (en) | PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF THEIR USE | |
BR9803385A (en) | Atropisomers of 2,3-disubstituted- (5,6) -heteroaryl condensate-pyrimidin-4-ones. | |
HUP0100611A2 (en) | Triazine compounds for treatment of cns disorders | |
ES2124861T3 (en) | AMINO ACID DERIVATIVES AND THEIR USE AS ENCEPHALINASE INHIBITORS. | |
NO982863L (en) | New compounds with analgesic effect | |
ES2089286T3 (en) | NEW 2-AMINO-5-CIANO-1,4-DIHIDROPIRIDINAS, PROCEDURE FOR ITS PREPARATION AND USE IN MEDICINES. | |
NO984651L (en) | Use of benzone-offset derivatives for the manufacture of drugs for the treatment of central nervous system diseases | |
TR199901385T2 (en) | Piperidin t�revleri. | |
PT889044E (en) | DERIVATIVES OF 5- (HETEROARIL) ALTAL-3-OXO-PYRID- (1,2-A) BENZIMIDAZOLE-4-CARBOXAMIDE (GDP) USEFUL IN TREATING PERTURBACTIONS OF THE CENTRAL NERVOUS SYSTEM | |
BR9714184A (en) | Use of bonzoillyl-1,2,3,6-tetrahydropyridines | |
TR200000916T2 (en) | Substituted piperidine derivatives. |